The Pharma Data

NOVEMBER 20, 2020

In 2006, 0.2% “There could be multiple barriers to patients reporting this to their provider,” Crawford said, including stigma, guilt or even fear that the doctor will call child protective services. As it stands, doctors are encouraged to screen pregnant women and new mothers for depression symptoms.

Doctors 52

Doctors Government Hospitals Research 52

FDA Law Blog: Biosimilars

NOVEMBER 1, 2023

Unlike hospital reprocessing facilities, many clinical laboratories are overseen by laboratory directors who themselves are medical doctors. In support for this position, FDA states that hospitals that reprocess single-use devices have been viewed as manufacturers and points to its own webpage for support. This comparison is misplaced.

Laboratories 81

Laboratories FDA Regulations Licensing 81

Agency IQ

FEBRUARY 12, 2024

since June 21, 2006. The document notably recommends that doctors consider testing for PFAS in blood and explains some of the current research associating PFAS and adverse health effects [additional AgencyIQ analysis of the document available here ].

Regulations 40

Regulations Packaging Production Doctors 40

Agency IQ

SEPTEMBER 15, 2023

In 2006, the FDA amended its final rule to add phenylephrine bitartrate (an effervescent formulation) to phenylephrine hydrochloride as GRASE over-the-counter nasal decongestant products included in that final monograph. To reach all consumers, the advisors want the agency to execute a comprehensive strategy.

Science 40

Science FDA Clinical Trials Clinical Pharmacology 40

The Pharma Data

AUGUST 19, 2020

The lawsuit accused the companies of insurance fraud and for downplaying the risks of their opioid painkillers to both doctors and patients. New York State also says Teva made 20% of all opioids distributed from 2006 to 2014 in the region and marketed its products for off-label uses. Both companies deny the charges. .

Pharmaceuticals 52

Pharmaceuticals Doctors International FDA 52

FDA Law Blog: Biosimilars

MARCH 15, 2023

See Government Accountability Office, “ GAO-06-724 Mammography: Current Nationwide Capacity Is Adequate, but Access Problems May Exist in Certain Locations ” (July 2006). ” However, it can also be among the most difficult images to interpret.

Regulations 59

Regulations FDA Doctors Government 59

The Pharma Data

MAY 15, 2023

Before joining Solvias Group, Karen held various senior leadership roles at Novartis, including global head investor relations from 2000 to 2006, head M&A and Executive Committee member, as well as site head for the Vaccines & Diagnostics division between 2006 and 2011.

Science 40

Science Doctors Government Pharmaceuticals 40

The Pharma Data

AUGUST 16, 2020

“We are very optimistic the addition of this new approved treatment option will make a meaningful difference for those living with NMOSD, those who love and support them and the doctors who treat them,” said Victoria Jackson, founder, The Guthy-Jackson Charitable Foundation. About neuromyelitis optica spectrum disorder (NMOSD).

FDA Approval 52

FDA Approval FDA Clinical Trials Treatment 52

Codon

AUGUST 27, 2024

Doctors in training are told that when they hear hoofbeats, they should think horses, not zebras; rare diseases are the exception, not the rule. This speedy and well-connected surveillance network grew out of changes made between 2002 and 2006 when USAID and the U.S. This is the third essay of four in our pandemic mini-issue.

DNA 109

DNA Laboratories Hospitals Virus 109

Alta Sciences

MARCH 4, 2025

This was in 2006, at a time when the FDA guidances on these topics had not yet been published. She earned a doctorate in Pharmacology and the Collaborative Program in Neuroscience from the University of Torontowhere she currently holds an appointment as an Adjunct Professor.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

Drug Target Review

APRIL 28, 2025

He then proceeded to a post-doctoral position at Royal Holloway, University of London, where he worked on developing novel gene therapies for Duchennes Muscular Dystrophy. In 2004 he moved into the Biotech sector, spending five years running Gene Therapy R&D activities for Regulon Inc, joining the board in 2006.

Therapies 59

Therapies Regulations Bioinformatics Clinical Development 59

Codon

MAY 22, 2025

He was rushed to Walter Reed Army Medical Center, one of the best hospitals of the day, but despite the doctors’ efforts, sixteen-year-old Calvin Jr. The story of the tetracycline destructases, the subject of my doctoral research in Gautam Dantas’ lab , bears out the value of such a proactive approach.

DNA 97

DNA Laboratories Doctors Production 97

Codon

FEBRUARY 23, 2025

Doctors began prescribing combinations of three or more antiretrovirals in 1995, making it unlikely that a mutant HIV strain resistant to one drug could evade the others. The painkiller rofecoxib , for example, was licensed before doctors discovered it increased the risk of cardiovascular disease.)

Clinical Trials 76

Clinical Trials Virus Vaccine DNA 76

Drug & Device Law

DECEMBER 4, 2023

Taking the good doctor first, In re Philips Recalled CPAP, Bi-Level Pap, & Mechanical Ventilator Products Litigation , 2023 WL 7019667 (Sp. 2006), aff’d , 526 F.3d 2006), holds that “same rational applicable to prescription drugs” applies to medical devices. Ackermann v. Wyeth Pharmaceuticals , 471 F. 2d 739, 747 (E.D.

Production 52

Production Trials Treatment Pharmaceuticals 52

Drug & Device Law

NOVEMBER 14, 2023

2006); Orzel v. All connections alleged were with [the lead defendant] and his doctors. We’ve discussed several times how such plaintiffs (or their estates) should lose under the in pari delicto doctrine that prevents criminals from recovering damages for the consequences of their own criminal acts. Lots of cases so hold.

Production 59

Production Drugs Doctors Laboratories 59

Drug & Device Law

JULY 11, 2023

Plaintiff received silicone-filled breast implants in 2006. Plaintiff’s argument for why her claim was timely filed is that she first learned of the alleged connection between silicone breast implants and Lupus from her doctor in August 2020. Following the rupture of one of the implants, they were both removed in 2017.

Doctors 45

Doctors Disease 45

Drug & Device Law

FEBRUARY 10, 2023

That manufacturer had relinquished all of its rights to Zantac in December 2006 – eight years before plaintiff began using it in 2014. All of us who practice on the right side of the “v.” The implausibility of the claims against the sole non-diverse manufacturer satisfied the exacting fraudulent joinder standard.

Pharmacy 52

Pharmacy Production Pharmaceuticals Doctors 52

Drug & Device Law

JUNE 6, 2022

Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” June 29, 2017) (no causation where “[t]he prescribing doctors would not have changed their prescriptions based on what they now know about [the drug]”); Lord v. Sigueiros , 2006 WL 1510408, at *3 (Cal.

Testimonials 59

Testimonials Production Pharmaceuticals Drugs 59

Drug & Device Law

MAY 30, 2022

The law presumes that licensed doctors know what they are doing. 1978), where a hypertensive patient was injured after being injected with the defendant’s drug – despite warnings that “expressly directed the doctor administering the drug to refrain from giving it to a patient with hypertension.” Best Pharmacal , 577 P.2d Robins Co. ,

Testimonials 59

Testimonials Doctors Production Laboratories 59

Drug & Device Law

MAY 26, 2022

They also had to have been made between the May 2006 PMA approval and the June 2007 implant, and been relied upon by the implanting surgeon or the plaintiff. (We But it was consistent with the rate in the approved IFU at the time and plaintiff had no evidence that she or her doctor relied on the undifferentiated rate.

Doctors 59

Doctors FDA FDA Approval Production 59

Drug & Device Law

APRIL 29, 2022

2d 1114 (2006). Then, he continued, the doctor “provided a scientific expression of [the decedent’s] exposure level to asbestos” based on relevant literature, the geologist’s test results, and the evidence of the decedent’s daily routine. at *3, (internal punctuation omitted, citing Parker v. Mobil Oil Corp., 3d 434, 448, 824 N.Y.S.2d

Testimonials 52

Testimonials International Production Doctors 52

Drug & Device Law

MARCH 22, 2022

While it mentions marketing and presentations made to doctors, the complaint “does not specifically allege how any of these marketing efforts reached [plaintiff’s] pediatrician.” Plaintiff made only conclusory allegations about profit motive, so her fraud claims failed on this basis as well.

Vaccine 59

Vaccine Production FDA FDA Approval 59